buserelin has been researched along with Adenocarcinoma, Papillary in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Douvdevani, A; Kleinman, D; Levy, J; Schally, AV; Sharoni, Y | 1 |
1 other study(ies) available for buserelin and Adenocarcinoma, Papillary
Article | Year |
---|---|
Direct growth inhibition of human endometrial cancer cells by the gonadotropin-releasing hormone antagonist SB-75: role of apoptosis.
Topics: Adenocarcinoma, Papillary; Aged; Apoptosis; Buserelin; Cell Cycle; Cell Division; DNA, Neoplasm; Dose-Response Relationship, Drug; Electrophoresis, Agar Gel; Endometrial Neoplasms; Estradiol; Female; Flow Cytometry; Gonadotropin-Releasing Hormone; Humans; Receptors, Estrogen; Time Factors; Tumor Cells, Cultured | 1994 |